48 related articles for article (PubMed ID: 12903579)
21. [Renal transplantation in patients with HIV infection].
Trullás JC; Miró JM; Barril G; Ros S; Burgos FJ; Moreno A; Mazuecos A; Alvarez-Vijande R; Oppenheimer F; Carmen Sánchez M; Blanco JL; Tuset M; Torre-Cisneros J; Polo R; González J
Enferm Infecc Microbiol Clin; 2005; 23(6):363-74. PubMed ID: 15970170
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan.
Eguchi S; Soyama A; Hidaka M; Takatsuki M; Muraoka I; Tomonaga T; Kanematsu T
Surg Today; 2011 Oct; 41(10):1325-31. PubMed ID: 21922353
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma in patients with HIV.
Dika IE; Harding JJ; Abou-Alfa GK
Curr Opin HIV AIDS; 2017 Jan; 12(1):20-25. PubMed ID: 27755152
[TBL] [Abstract][Full Text] [Related]
24. Human Immunodeficiency Virus in Kidney Transplantation.
Degnan KO; Blumberg EA
Semin Nephrol; 2016 Sep; 36(5):405-416. PubMed ID: 27772625
[TBL] [Abstract][Full Text] [Related]
25. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology.
Sonderup MW; Wainwright HC
Gastroenterol Clin North Am; 2017 Jun; 46(2):327-343. PubMed ID: 28506368
[TBL] [Abstract][Full Text] [Related]
26. Hepatotoxicity of antiretroviral drugs.
Abrescia N; D'Abbraccio M; Figoni M; Busto A; Maddaloni A; De Marco M
Curr Pharm Des; 2005; 11(28):3697-710. PubMed ID: 16305505
[TBL] [Abstract][Full Text] [Related]
27. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection.
Orenstein R; Tsogas N
Pharmacotherapy; 2002 Nov; 22(11):1468-78. PubMed ID: 12432973
[TBL] [Abstract][Full Text] [Related]
28. Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients.
Barve S; Kapoor R; Moghe A; Ramirez JA; Eaton JW; Gobejishvili L; Joshi-Barve S; McClain CJ
Alcohol Res Health; 2010; 33(3):229-36. PubMed ID: 23584064
[TBL] [Abstract][Full Text] [Related]
29. [Antiretroviral agents in HIV-infected patients with cirrhosis].
Salmon-Céron D; Sogni P; Spiridon G; Taburet AM
Presse Med; 2005 Jun; 34(10 Suppl):1S45-52. PubMed ID: 16025667
[TBL] [Abstract][Full Text] [Related]
30. Highly active antiretroviral therapy-induced liver injury.
Inductivo-Yu I; Bonacini M
Curr Drug Saf; 2008 Jan; 3(1):4-13. PubMed ID: 18690975
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral-associated liver injury.
Ogedegbe AO; Sulkowski MS
Clin Liver Dis; 2003 May; 7(2):475-99. PubMed ID: 12879995
[TBL] [Abstract][Full Text] [Related]
32. Modern anti-HIV therapy.
Flepp M; Schiffer V; Weber R; Hirschel B
Swiss Med Wkly; 2001 Apr; 131(15-16):207-13. PubMed ID: 11400543
[TBL] [Abstract][Full Text] [Related]
33. Evolution of HIV-1-related conjunctival molluscum contagiosum under HAART: report of a bilaterally manifesting case and literature review.
Schulz D; Sarra GM; Koerner UB; Garweg JG
Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):951-5. PubMed ID: 15221307
[TBL] [Abstract][Full Text] [Related]
34. The pathology induced by highly active antiretroviral therapy against human immunodeficiency virus: an update.
Hofman P; Nelson AM
Curr Med Chem; 2006; 13(26):3121-32. PubMed ID: 17168701
[TBL] [Abstract][Full Text] [Related]
35. HIV protease inhibitors in gut barrier dysfunction and liver injury.
Wu X; Li Y; Peng K; Zhou H
Curr Opin Pharmacol; 2014 Dec; 19():61-6. PubMed ID: 25105480
[TBL] [Abstract][Full Text] [Related]
36. Peripheral neuropathies in HIV-infected patients in the era of HAART.
Authier FJ; Gheradi RK
Brain Pathol; 2003 Apr; 13(2):223-8. PubMed ID: 12744475
[No Abstract] [Full Text] [Related]
37. HIV-infected patients and liver transplantation: who, when and why.
Tavio M; Grossi P; Baccarani U; Scudeller L; Pea F; Berretta M; Adani G; Vivarelli M; Riva A; Tirelli U; Bresadola V; Viale P; Risaliti A
Curr HIV Res; 2011 Mar; 9(2):120-7. PubMed ID: 21222618
[TBL] [Abstract][Full Text] [Related]
38. Solid organ transplantation in HIV-positive patients.
Stock P; Roland M; Carlson L; Freise C; Hirose R; Terrault N; Frassetto L; Coates T; Roberts J; Ascher N
Transplant Proc; 2001; 33(7-8):3646-8. PubMed ID: 11750549
[No Abstract] [Full Text] [Related]
39. The nephrotoxic effects of HAART.
Izzedine H; Harris M; Perazella MA
Nat Rev Nephrol; 2009 Oct; 5(10):563-73. PubMed ID: 19776778
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of endogenous and exogenous metabolites in liver transplantation.
Xiong XF; Chen DD; Zhu HJ; Ge WH
Biomark Med; 2020 Aug; 14(12):1165-1181. PubMed ID: 32969246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
